Stay updated on Pyrotinib Combo in HR+/HER2- Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Combo in HR+/HER2- Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T16:30:50.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-25T19:18:46.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:35:36.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T22:41:02.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new site revision entry (v3.7.0) was added to the record history, replacing the previous revision (v3.6.6), indicating a platform update for the study history page. This is a metadata update and does not alter the study information displayed.
    Difference
    0.1%
    Check dated 2026-09-20T22:33:04.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    A new Revision: v3.6.6 entry was added to the study record history, and the previous Revision: v3.6.5 entry was removed.
    Difference
    0.1%
    Check dated 2026-08-30T21:54:14.000Z thumbnail image

Stay in the know with updates to Pyrotinib Combo in HR+/HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.